Directa Plus PLC's shares fell 17.5% after the company warned it could enter administration if it fails to secure new funding within weeks. The graphene products firm is in advanced talks with an unnamed investor for up to £2.5 million but cautions no deal is guaranteed. Previous funding talks with Nant Capital collapsed. With cash reserves dwindling to €1.5 million at the end of 2025, the company faces a critical cash runway only until early May. It is also considering selling non-strategic land and its Romanian subsidiary Setcar to raise funds. Shareholder approval is needed for the proposed funding facility, and the board is exploring broader options to sustain the business.
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
